White matter hyperintensities and late-life cognition: an analysis of moderation effects of mild behavioral impairment

白质高信号与晚年认知:轻度行为障碍的调节效应分析

阅读:1

Abstract

BACKGROUND: Mild behavioral impairment (MBI) is recognized as a potential early marker for dementia and may be indicative of the increased risk in the predementia stage. This study investigated whether MBI could moderate the impact of white matter hyperintensities (WMHs) on late-life cognitive function in patients with arteriosclerotic cerebral small vessel disease (aCSVD). METHODS: Patients were categorized into two groups based on Fazekas scores: low WMH burden (LWMH, scores 1-2; n = 119) and high WMH burden (HWMH, scores 3-6; n = 110). Logistic regression analysis was used to assess the associations among WMH, MBI, and screen-positive cognitive impairment. Moderation analysis was conducted to evaluate whether the presence of MBI could influence the relationship between WMH and cognitive outcomes. RESULTS: WMH was associated with MBI (p < 0.001) and screen-positive cognitive impairment (MoCA: p = 0.003; MMSE: p = 0.025), and MBI was correlated with screen-positive cognitive impairment (p = 0.010 and 0.007, respectively). HWMH was independently correlated with screen-positive cognitive impairment and MBI (p = 0.001; p < 0.001; p = 0.031). Compared with cases in the non-MBI group, those in the MBI group had more WMHs in the occipital lobes (p = 0.016) and subcortical structures (p = 0.042). Furthermore, MBI significantly moderated the association between WMH and screen-positive cognitive impairment (β = -0.10, p < 0.014; β = -0.06, p < 0.041). CONCLUSION: The presence of MBI may exacerbate the cognitive decline associated with WMH in patients with aCSVD. These findings highlight the importance of early identification and monitoring of MBI in cases with WMH to better assess dementia risk and to develop interventional strategies.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。